(Q40261976)

English

Vaccinia virus K1L protein supports viral replication in human and rabbit cells through a cell-type-specific set of its ankyrin repeat residues that are distinct from its binding site for ACAP2.

scientific article published on 30 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Vaccinia virus K1L protein supports viral replication in human and rabbit cells through a cell-type-specific set of its ankyrin repeat residues that are distinct from its binding site for ACAP2. (English)

1 reference

Europe PubMed Central

19 September 2017

object named as

Vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Xiangzhi Meng

1

1 reference

Europe PubMed Central

19 September 2017

Yan Xiang

2

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

30 June 2006

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

353

1 reference

Europe PubMed Central

19 September 2017

1

1 reference

Europe PubMed Central

19 September 2017

220-233

1 reference

Europe PubMed Central

19 September 2017

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Anatomy of hot spots in protein interfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

A hot spot of binding energy in a hormone-receptor interface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

AIDS vaccines. HIV dodges one-two punch

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

A binding free energy hot spot in the ankyrin repeat protein GABPbeta mediated protein-protein interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Host range deletion mutant of vaccinia virus defective in human cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Localization and sequence of a vaccinia virus gene required for multiplication in human cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

The cowpox virus host range gene, CP77, affects phosphorylation of eIF2 alpha and vaccinia viral translation in apoptotic HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

ACAPs are arf6 GTPase-activating proteins that function in the cell periphery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Designed to be stable: crystal structure of a consensus ankyrin repeat protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

SMART 4.0: towards genomic data integration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Poxvirus tropism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

The ankyrin repeat as molecular architecture for protein recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Crystal Structure of the Homolog of the Oncoprotein Gankyrin, an Interactor of Rb and CDK4/6

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Vaccinia virus host range genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

The ankyrin repeat: a diversity of interactions on a common structural framework

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Current progress in the development of HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Marker rescue of the host range restriction defects of modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.032

7 January 2021

Identifiers

10.1016/J.VIROL.2006.05.032

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40261976&oldid=1654691296"